Product Description:

Hyaluronidase LDRASE 1 Vial is a sterile lyophilized powder containing recombinant human hyaluronidase. It is intended for use as an adjuvant in subcutaneous or intramuscular injections to increase the dispersion and absorption of other injected drugs, particularly hyaluronic acid-based dermal fillers.

Key Features:

• Recombinant Human Hyaluronidase: Contains highly purified recombinant human hyaluronidase enzyme.
• Lyophilized Powder: Comes in a freeze-dried powder form for reconstitution before use.
• Adjuvant Function: Facilitates the dispersion and absorption of injected drugs, especially hyaluronic acid-based fillers.
• Sterile Packaging: Each vial is individually sealed and sterilized to maintain product integrity.
• Single-Use: Designed for single-use applications to prevent contamination and ensure safety.

Benefits:

• Improved Drug Absorption: Enhances the diffusion and spread of injected medications, improving their effectiveness.
• Reduced Filler Complications: Minimizes the risk of complications associated with hyaluronic acid-based fillers, such as lumps or nodules.
• Versatile Use: Compatible with various injectable medications and suitable for a range of aesthetic and medical procedures.
• Convenient Packaging: Convenient single-use vial packaging for easy handling and administration.

Usage Instructions:

1. Reconstitution: Reconstitute the lyophilized powder with the appropriate diluent according to the manufacturer’s instructions.
2. Injection Technique: Administer the reconstituted solution subcutaneously or intramuscularly at the desired injection site.
3. Dosage: Determine the appropriate dosage based on the patient’s anatomy, the type of filler used, and the desired outcome.
4. Monitoring: Monitor the patient for any adverse reactions or complications post-injection and provide appropriate follow-up care if needed.

Suitable For:

• Healthcare professionals trained in injectable procedures, including dermatologists, plastic surgeons, and aesthetic practitioners.
• Patients undergoing dermal filler injections who require improved filler dispersion or correction of filler-related complications.

Package Includes:

• 1 vial of Hyaluronidase LDRASE lyophilized powder
• Package insert with reconstitution and administration instructions

Safety and Quality Assurance:

• Manufactured in compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety.
• Each batch undergoes rigorous quality control testing to verify purity, potency, and sterility.
• Designed for single-use applications to prevent cross-contamination and ensure patient safety.

Storage Instructions:

• Store Hyaluronidase LDRASE vials at room temperature (20°C to 25°C) away from direct sunlight.
• Avoid freezing or exposing the product to extreme temperatures.
• Discard any unused portion of the reconstituted solution.

Caution:

• For professional use only by trained healthcare practitioners.
• Use with caution in patients with a history of hypersensitivity reactions to hyaluronidase or any other ingredient in the formulation.
• Adverse reactions may include local injection site reactions, allergic reactions, or rare cases of anaphylaxis.